Literature DB >> 110697

Antigenic differences between extracts of actively replicating and synchronized resting cells of Mycobacterium tuberculosis.

L G Wayne, H A Sramek.   

Abstract

Protein extracts were prepared from aerobically replicating cells of Mycobacterium tuberculosis and from synchronized non-replicating cells derived from the sediments of non-agitated cultures. Although both preparations share a number of antigens, the extracts of the non-replicating cells also contain antigenic components that are not shared by the replicating cells, and which can be isolated and visualized by immunoaffinity chromatography and immunoelectrophoretic techniques.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 110697      PMCID: PMC414310          DOI: 10.1128/iai.24.2.363-370.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  Immunological method to differentiate between antigens of tubercle bacilli, other mycobacterial species, and non-acid-fast bacteria.

Authors:  H R Ferguson; J K McClatchy; T R Sharpton; P Minden
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

2.  Production and assay of antibodies against one antigenic component of Mycobacterium bovis BCG.

Authors:  M Harboe; O Closs; K Svindahl; J Deverill
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

3.  Isolation and characterization of catalase produced by Mycobacterium tuberculosis.

Authors:  G A Diaz; L G Wayne
Journal:  Am Rev Respir Dis       Date:  1974-09

4.  The isolation by immunoabsorbent affinity chromatography and physicochemical characterization of Mycobacterium tuberculosis antigen 5.

Authors:  T M Daniel; P A Anderson
Journal:  Am Rev Respir Dis       Date:  1978-03

5.  Autolysis and secondary growth of Mycobacterium tuberculosis in submerged culture.

Authors:  L G Wayne; G A Diaz
Journal:  J Bacteriol       Date:  1967-04       Impact factor: 3.490

6.  Yield of non-dialyzable mycobacterial constituents during the growth cycle.

Authors:  R Turcotte
Journal:  Can J Microbiol       Date:  1969-01       Impact factor: 2.419

7.  The variations in the antigenic composition of Mycobacterium tuberculosis during the growth cycle as measured by the passive hemagglutination and precipitation reactions.

Authors:  R Turcotte
Journal:  Can J Microbiol       Date:  1969-07       Impact factor: 2.419

8.  Synchronized replication of Mycobacterium tuberculosis.

Authors:  L G Wayne
Journal:  Infect Immun       Date:  1977-09       Impact factor: 3.441

9.  A reference system for antigens of Mycobacterium tuberculosis.

Authors:  B W Janicki; S D Chaparas; T M Daniel; G P Kubica; G L Wright; G S Yee
Journal:  Am Rev Respir Dis       Date:  1971-10

10.  Environmental control of glycogen and lipid content of Mycobacterium tuberculosis.

Authors:  A D Antoine; B S Tepper
Journal:  J Bacteriol       Date:  1969-10       Impact factor: 3.490

View more
  16 in total

1.  Proteins of Mycobacterium bovis BCG induced in the Wayne dormancy model.

Authors:  C Boon; R Li; R Qi; T Dick
Journal:  J Bacteriol       Date:  2001-04       Impact factor: 3.490

2.  Microaerophilic induction of the alpha-crystallin chaperone protein homologue (hspX) mRNA of Mycobacterium tuberculosis.

Authors:  L E Desjardin; L G Hayes; C D Sohaskey; L G Wayne; K D Eisenach
Journal:  J Bacteriol       Date:  2001-09       Impact factor: 3.490

3.  Mycobacterium bovis BCG response regulator essential for hypoxic dormancy.

Authors:  Calvin Boon; Thomas Dick
Journal:  J Bacteriol       Date:  2002-12       Impact factor: 3.490

4.  Immunoglobulin A (IgA) and IgG serum antibodies to mycobacterial antigens in Crohn's disease patients and their relatives.

Authors:  L G Wayne; D Hollander; B Anderson; H A Sramek; C M Vadheim; J I Rotter
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

Review 5.  Dormancy of Mycobacterium tuberculosis and latency of disease.

Authors:  L G Wayne
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

6.  An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence.

Authors:  L G Wayne; L G Hayes
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

7.  Discovery of selective menaquinone biosynthesis inhibitors against Mycobacterium tuberculosis.

Authors:  Joy Debnath; Shajila Siricilla; Bajoie Wan; Dean C Crick; Anne J Lenaerts; Scott G Franzblau; Michio Kurosu
Journal:  J Med Chem       Date:  2012-04-06       Impact factor: 7.446

8.  MenA is a promising drug target for developing novel lead molecules to combat Mycobacterium tuberculosis.

Authors:  Michio Kurosu; Dean C Crick
Journal:  Med Chem       Date:  2009-03       Impact factor: 2.745

9.  The 16-kDa alpha-crystallin (Acr) protein of Mycobacterium tuberculosis is required for growth in macrophages.

Authors:  Y Yuan; D D Crane; R M Simpson; Y Q Zhu; M J Hickey; D R Sherman; C E Barry
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

10.  Antibodies to mycobacterial peptidoglycolipid and to crude protein antigens in sera from different categories of human subjects.

Authors:  L G Wayne; B Anderson; K Chetty; R W Light
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.